Evidence map›Paper›PMID 41199107›Full record

ArticleAnnals of surgical oncology2026

The Prognostic Role of Lymphadenectomy during Esophagectomy for Esophageal Cancer with Complete or Near-Complete Tumor Response after Neoadjuvant Therapy.

Wilhelm Leijonmarck, Fredrik Mattsson, Eivind Gottlieb-Vedi, Ellinor Wiström, Joonas H Kauppila, FINEGO group, Jesper Lagergren

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wilhelm LeijonmarckDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. wilhelm.leijonmarck@ki.se.ORCID http://orcid.org/0000-0003-1054-512X
Fredrik MattssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Eivind Gottlieb-VediDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Ellinor WiströmDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Joonas H KauppilaDepartment of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.
FINEGO group
Jesper LagergrenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic role of lymphadenectomy during esophagectomy for esophageal cancer in complete responders to neoadjuvant therapy is uncertain. This study aimed to help clarify this question. PATIENTS AND

methodsThis was a bi-national population-based cohort study in Sweden (2006-2024) and Finland (2006-2019). The main cohort included 515 patients with esophageal cancer who underwent esophagectomy after complete or near-complete tumor response without lymph node metastasis following neoadjuvant therapy. A secondary cohort included 669 patients with similar tumor response, regardless of nodal status. Data came from medical records and national health data registers. Associations between lymphadenectomy (categorized in quartiles) and 5-year mortality were assessed using multivariable Cox regression, yielding hazard ratios (HR) with 95% confidence intervals (CI), adjusted for age, sex, country, comorbidity, type of neoadjuvant therapy, calendar year, tumor histology, hospital volume, tumor location, tumor response, and T stage.

resultsIn the main cohort, comparing the highest quartile of lymphadenectomy (≥ 27 nodes) with the lowest (0-11 nodes) indicated decreased 5-year all-cause mortality (HR 0.54, 95% CI 0.34-0.88). Stratified analyses suggested no significant association for complete responders (HR 0.68, 95% CI 0.39-1.16), but for near-complete responders (HR 0.32, 95% CI 0.14-0.72). The associations disappeared when assessing stage purification bias in the secondary cohort (n = 669), with the corresponding HRs of 0.91 (95% CI 0.63-1.32) for all responders, 1.01 (95% CI 0.61-1.66) for complete responders, and 0.79 (95% CI 0.47-1.33) for near-complete responders. Results were similar for 5-year disease-specific mortality.

conclusionsAfter considering stage purification bias, more extensive lymphadenectomy did not improve the long-term survival among patients with complete or near-complete tumor response after neoadjuvant therapy.

Indexed as

Esophageal NeoplasmsEsophagectomyLymph Node ExcisionNeoadjuvant TherapyAgedFemaleFinlandFollow-Up StudiesHumansLymphatic MetastasisMaleMiddle AgedPrognosisSurvival RateSweden

Identifiers

PMID41199107
PMCPMC12901257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.